Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis.

Li, D K

Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. [electronic resource] - Annals of neurology Aug 1999 - 197-206 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0364-5134

10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p doi


Adult
Double-Blind Method
Female
Humans
Interferon beta-1a
Interferon-beta--therapeutic use
Magnetic Resonance Imaging
Male
Multiple Sclerosis--pathology
Prognosis
Recurrence